BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10684726)

  • 1. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart.
    Maxwell L; Harrison WR; Gavin JB
    Microvasc Res; 2000 Mar; 59(2):204-12. PubMed ID: 10684726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
    Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
    Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion.
    Hagar JM
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1833-41. PubMed ID: 7977813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-3-induced microvascular incompetence and mitochondrial damage in rat myocardium.
    Maxwell L; Pratt K; Gavin J
    Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):683-8. PubMed ID: 1424296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of post-ischaemic reperfusion in the development of microvascular incompetence and ultrastructural damage in the myocardium.
    Maxwell L; Gavin JB
    Basic Res Cardiol; 1991; 86(6):544-53. PubMed ID: 1786035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.
    Fontaine ER; Viau S; Jasmin G; Dumont L
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):12-20. PubMed ID: 9676715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ET(B) receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD 155080 and BQ-788.
    Brunner F; Doherty AM
    FEBS Lett; 1996 Nov; 396(2-3):238-42. PubMed ID: 8914994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea-pig heart.
    Kurzelewski M; Czarnowska E; Beresewicz A
    Eur J Pharmacol; 2002 Jan; 434(1-2):95-107. PubMed ID: 11755171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence.
    Goyal SN; Bharti S; Arora S; Golechha M; Arya DS
    Biomed Pharmacother; 2010 Nov; 64(9):639-46. PubMed ID: 20888175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610.
    Han H; Neubauer S; Braeker B; Ertl G
    J Mol Cell Cardiol; 1995 Feb; 27(2):761-6. PubMed ID: 7776381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of BQ-485, a selective ETA antagonist, on endothelin-mediated vasomotion in rat coronary vascular beds.
    Sakuma I; Asajima H; Fukao M; Tohse N; Tamura M; Kitabatake A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S400-3. PubMed ID: 8587427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of microcirculation by coloured microspheres and NMR-microscopy in isolated rat heart: effect of ischaemia, endothelin-1 and endothelin-1 antagonist BQ 610.
    Hiller KH; Roder F; Adami P; Voll S; Kowallik P; Haase A; Ertl G; Bauer WR
    J Mol Cell Cardiol; 1997 Nov; 29(11):3115-22. PubMed ID: 9405185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury.
    Neubauer S; Zimmermann S; Hirsch A; Pulzer F; Tian R; Bauer W; Bauer B; Ertl G
    J Mol Cell Cardiol; 1991 Dec; 23(12):1397-409. PubMed ID: 1811056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transmural progression of the no-reflow phenomenon in globally ischemic hearts.
    Sheppard AJ; Gavin JB
    Basic Res Cardiol; 1988; 83(6):611-7. PubMed ID: 3223877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH; Warner TD
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
    Hiramatsu T; Forbess J; Miura T; Roth SJ; Cioffi MA; Mayer JE
    Circulation; 1995 Nov; 92(9 Suppl):II400-4. PubMed ID: 7586445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidant therapy improves microvascular ultrastructure and perfusion in postischemic myocardium.
    Maxwell L; Gavin J
    Microvasc Res; 1992 May; 43(3):255-66. PubMed ID: 1635471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin and free radicals modulate microvascular responses in streptozotocin-induced diabetic rats.
    Bassirat M; Khalil Z
    Microvasc Res; 2000 Jan; 59(1):88-98. PubMed ID: 10625575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
    Xia Z; Kuo KH; McNeill JH; Ansley DM
    Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ET(A) receptor blockade improves post-ischaemic functional recovery in 'hibernating' rat myocardium.
    Beyer ME; Fischer M; Hövelborn T; Hoffmeister HM
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():215S-218S. PubMed ID: 12193089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.